Peritoneal Malignancy

Peritoneal Surface Malignancy (HIPEC Surgery)

Cytoreductive Surgery (CRS): is a procedure to remove the cancerous tissues from the abdomen. This is a major surgery which removes all visible evidence of disease from the abdomen. It involves removal of disease from peritoneum, omentum and abdominal viscera. This systemic procedure may also involve resection and reanastomosis of part of bowel for complete removal of disease. This adequacy of long cytoreductive surgery is the decisive factor to further proceed with HIPEC. When as many tumors as possible have been removed, a heated, sterilized chemotherapy solution is delivered to the abdomen to penetrate and destroy remaining cancer cells. The solution is 41 to 42 degrees Celsius, about the temperature of a warm bath. It’s circulated throughout the abdomen for approximately 90 minutes. The solution is then drained from the abdomen, and the incision is closed.

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a surgical procedure that’s giving new hope to patients with abdominal cancers. Immediately after removing visible tumors a heated, sterilized highly concentrated dose of chemotherapy solution is circulated inside the abdominal cavity at a temperature of around 42 degree Celsius. The drug penetrate and destroy microscopic cancer cells directly.

Advantages of CRS - HIPEC Surgery
  • Deeper penetration of the medicine direcly.
  • Greater effectiveness at killing cancer cells in the abdomen.
  • Allows for high doses of chemotherapy.
  • Enhances and concentrates chemotherapy within the abdomen.
  • Reduces the rest of the body’s exposure to the chemotherapy.
  • Improves chemotherapy absorption and susceptibility of cancer cells.
  • Reduces some chemotherapy side effects.

 

What Patients should know?

Cytoreductive Surgery is a very long and challenging surgery. Depending on site of tumors to be removed, operation can take as many as eight or nine hours, and chemotherapy application takes another two hours. There are requirements of blood products and post surgery ICU care and procedure associated complication rate. Patient may need nutritional support.

Cancers Treated by CRS+HIPEC Surgery
  • Colon and rectum cancers with peritoneal metastasis- abdomen only spread.
  • Appendix tumors such as
  • Pseudomyxoma peritonei
  • Low-grade appendiceal mucinous neoplasm ● Advance ovarian cancer with peritoneal metastasis
  • Primary Peritoneal Cancer
  • Peritoneal mesothelioma
  • Desmoplastic small round cell tumors
  • Select cases of endometrial cancers with peritoneal metastases, stomach cancer with peritoneal metastases, and other rarer peritoneal surface malignancies.
Request an appointment with expert in HIPEC Surgery

You can make an appointment with Dr Kaushal Yadav by:
● Scheduling an Online Consultation.
● Requesting an online second opinion from our specialists by sharing reports
● Writing on email id: arogyamcare123@gmail.com
To speak to someone directly, please call on +91 87505 87489 If you have symptoms of an urgent nature, please go to the emergency room immediately

To Book Appointment for Cancer Surgery :

Got some questions

Colon cancer can start anywhere in the colon, which is about 5 feet long and absorbs water from the stool. Rectal cancer begins in the rectum, which is the last 12 cm (about 5 inches) of the large intestine. This is where the body defecates until you have a bowel movement. Contact Cancer Surgery clinic Arogyam Care at Gurugram, Delhi NCR or book online appointment for colon and rectal cancer treatment in Gurgaon.
  • If all relavant examination and investigations has been done than plan of treatment is finalized with colon cancer surgeon
  • After deciding surgical procedure cost estimate can be taken from billing department or hospital. Clinic or hospital department coordinator will assist in case any help required. +918750587489,
Best Doctor for Rectal Cancer in Gurgaon says for rectal cancer, the overall 5-year survival rate for people is 67%. If the cancer is diagnosed locally, the survival rate is 89%. If the cancer has spread to surrounding tissues or organs and / or regional lymph nodes, the 5-year survival rate is 72%
It is 10 times more likely to cause stomach cancer than rectal cancer, where it returns after treatment has begun. Stomach cancer has about a 20 percent risk of local recurrence, versus about 2 percent with colon cancer. Contact Dr Kaushal Yadav for Cancer Surgery & for colon and rectal cancer treatment in Gurgaon, Delhi-NCR, India

Submit Your Query Here & We'll Get Back

12

To Book Appointment for Cancer Surgery :

Call Now Button